The global preterm birth diagnostic test kit market size was estimated at USD 157 million in 2024 and is projected to be worth around USD 329.65 million by 2034, growing at a CAGR of 7.7% from 2024 to 2034.
Preterm birth diagnostic test kits are products or instruments that are employed to determine preterm birth probabilities in expectant mothers. These tests enable clinicians to increase their chances of identifying women who are likely to deliver their babies prematurely; before 37 weeks. Also, high preterm birth rates contribute to market growth at an impressive speed.
The Global preterm birth diagnostic test kits market is being driven by the rising Preterm Birth Rate coupled with the need for early diagnosis. These kits help to perform timely and efficient assessment of possible preterm births with the help of biomarkers and clinical signs. The market is experiencing growth from increased understanding by healthcare personnel and pregnant women as well as the development of diagnostic tools.
North America primarily the United States has been one of the dominant regions in the preterm birth diagnostic test kits market. Advanced healthcare services, research development, and high awareness of prenatal care are the factors boosting a market share of preterm birth diagnostic test kits in the region.
Preterm Birth Diagnostic Test Kit Market Segmentation:
By Product
- FFN Test
- PAMG-1 Test
- IGFBP-1 Test
By Sample
- Blood
- Urine
- Vaginal Discharge
By End User
- Hospitals
- Diagnostic Laboratories
- Outpatient Clinics
- Research Centres
Preterm Birth Diagnostic Test Kit Market Companies:
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com